Let's talk prostate cancer - Digital Atlas
astellas Amgen lets talk
Let's talk prostate cancer - Digital Atlas
astellas lets talk

Let's talk prostate cancer
Digital Atlas
astellas lets talk
HOME ABOUT INCIDENCE MORTALITY SURVIVAL PROSTATE CANCER CARE QoL POLICIES GUIDELINES PATIENT STORIES LTPC CAMPAIGN RESOURCES CONTACT
HOME ABOUT INCIDENCE MORTALITY SURVIVAL PROSTATE CANCER CARE QoL POLICIES GUIDELINES PATIENT STORIES LTPC CAMPAIGN RESOURCES CONTACT PRIVACY NOTICE COOKIES

The Let’s Talk Prostate Cancer (LTPC) Digital Atlas provides an overview of prostate cancer outcomes across the EU and for each of the EU 27 countries and the UK.

The assumption that men with prostate cancer die with, rather than of prostate cancer, is a common misconception.1 Prostate cancer is a major health challenge with over 2 million people living with the disease across Europe, causing an estimated 107,000 deaths in 2018 alone.2,3 The time to act is now.

Download our Call to Action here

The LTPC campaign is a multidisciplinary and multi-stakeholder initiative to address the challenges faced by people affected by prostate cancer and increase its policy prioritisation across Europe. It is led by an Expert Group representing key prostate cancer stakeholder organisations, including Europa Uomo, the European Oncology Nursing Society (EONS), The European Association of Urology (EAU), and The European Association of Urology Nurses (EAUN).

 

 

1 Prostate Cancer UK. Separating fact from fiction: revealing the truth behind common prostate cancer myths. Accessible at https://prostatecanceruk.org/about-us/news-and-views/2019/7/prostate-cancer-mythbusting (last accessed September 2020)
2 Van Poppel, H et al. Prostate Cancer: Recommendations to lower the risk and mortality of the most frequent cancer in men. European Association of Urology. 2018. Accessible at https://uroweb.org/wp-content/uploads/EAU_WhitePaper_PCa_final.pdf (last accessed September 2020)
3 Van Poppel, H et al. Policy Paper on PSA Screening for Prostate Cancer. European Association of Urology. 2019. Accessible at http://epad.uroweb.org/wp-content/uploads/EAU_policy-briefing_PSA.pdf (last accessed September 2020)

 

 

.
×

 

LTPC CALL TO ACTION

The content of this call to action is informed by the Let’s Talk Prostate Cancer Expert Group organised and funded by Astellas Pharma Europe Ltd. to raise awareness of the challenges faced by people with advanced prostate cancer in Europe. The Expert Group is a collaborative initiative bringing together EU level stakeholders with a shared interest in promoting policy change, education and awareness to ensure that people with advanced prostate cancer receive the right treatment and care at the right time in a shared decision-making process between patients and medical professionals.

Download our Call to Action here


© 2019 -2023 Astellas Pharma Inc.

Astellas Pharma Inc., Amgen Inc., and Pfizer Inc. support the goals and objectives of the Let's Talk Prostate Cancer Expert Group. The activities of the Expert Group are funded by Astellas Pharma Europe Ltd. and Amgen Inc.